Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19:151–72. https://doi.org/10.1038/s41571-021-00573-2.

Article  CAS  PubMed  Google Scholar 

Makker V, Colombo N, Casado Herraez A, Santin AD, Colomba E, Miller DS, et al. Lenvatinib plus Pembrolizumab for advanced endometrial cancer. N Engl J Med. 2022;386:437–48. https://doi.org/10.1056/NEJMoa2108330.

Article  CAS  PubMed  Google Scholar 

Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The tumor microenvironment: A Milieu hindering and obstructing antitumor immune responses. Front Immunol. 2020;11:940 https://doi.org/10.3389/fimmu.2020.00940.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15:325–40. https://doi.org/10.1038/nrclinonc.2018.29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pottekat A, Menon AK. Subcellular localization and targeting of N-acetylglucosaminyl phosphatidylinositol de-N-acetylase, the second enzyme in the glycosylphosphatidylinositol biosynthetic pathway. J Biol Chem. 2004;279:15743–51. https://doi.org/10.1074/jbc.M313537200.

Article  CAS  PubMed  Google Scholar 

Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, et al. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature. 2019;571:127–31. https://doi.org/10.1038/s41586-019-1340-y.

Article  CAS  PubMed  Google Scholar 

Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature. 2011;480:118–22. https://doi.org/10.1038/nature10598.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, et al. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2020;69:888–900. https://doi.org/10.1136/gutjnl-2018-317163.

Article  CAS  PubMed  Google Scholar 

Dang CV. MYC on the path to cancer. Cell. 2012;149:22–35. https://doi.org/10.1016/j.cell.2012.03.003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19:1–11. https://doi.org/10.1128/MCB.19.1.1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morrison-Smith CD, Knox TM, Filic I, Soroko KM, Eschle BK, Wilkens MK, et al. Combined targeting of the BRD4-NUT-p300 axis in NUT Midline carcinoma by dual selective Bromodomain inhibitor, NEO2734. Mol Cancer Ther. 2020;19:1406–14. https://doi.org/10.1158/1535-7163.MCT-20-0087.

Article  CAS  PubMed  Google Scholar 

Patel MC, Debrosse M, Smith M, Dey A, Huynh W, Sarai N, et al. BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes. Mol Cell Biol. 2013;33:2497–507. https://doi.org/10.1128/MCB.01180-12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muhar M, Ebert A, Neumann T, Umkehrer C, Jude J, Wieshofer C, et al. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science. 2018;360:800–5. https://doi.org/10.1126/science.aao2793.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang CV, Reddy EP, Shokat KM, Soucek L. Drugging the ‘undruggable’ cancer targets. Nat Rev Cancer. 2017;17:502–8. https://doi.org/10.1038/nrc.2017.36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct Target Ther. 2018;3:5 https://doi.org/10.1038/s41392-018-0008-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Llombart V, Mansour MR. Therapeutic targeting of “undruggable” MYC. EBioMedicine. 2022;75:103756 https://doi.org/10.1016/j.ebiom.2021.103756.

Article  CAS  PubMed  Google Scholar 

Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T Cell metabolic insufficiency and dysfunction. Immunity. 2016;45:374–88. https://doi.org/10.1016/j.immuni.2016.07.009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gutzmer R, Stroyakovskiy D, Gogas H, Robert C, Lewis K, Protsenko S, et al. Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF(V600) mutation-positive melanoma (IMspire150): Primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;395:1835–44. https://doi.org/10.1016/S0140-6736(20)30934-X.

Article  CAS  PubMed  Google Scholar 

Rodell CB, Arlauckas SP, Cuccarese MF, Garris CS, Li R, Ahmed MS, et al. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng. 2018;2:578–88. https://doi.org/10.1038/s41551-018-0236-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, et al. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019;68:1653–66. https://doi.org/10.1136/gutjnl-2019-318419.

Article  CAS  PubMed  Google Scholar 

Xu D, Shao F, Bian X, Meng Y, Liang T, Lu Z. The evolving landscape of noncanonical functions of metabolic enzymes in cancer and other pathologies. Cell Metab. 2021;33:33–50. https://doi.org/10.1016/j.cmet.2020.12.015.

Article  CAS  PubMed  Google Scholar 

Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732–44. https://doi.org/10.1016/j.cell.2011.03.054.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahl PB, Young RA. MYC and transcription elongation. Cold Spring Harb Perspect Med. 2014;4:a020990 https://doi.org/10.1101/cshperspect.a020990.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Durbin AD, Zimmerman MW, Dharia NV, Abraham BJ, Iniguez AB, Weichert-Leahey N, et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat Genet. 2018;50:1240–6. https://doi.org/10.1038/s41588-018-0191-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schoenfelder S, Fraser P. Long-range enhancer-promoter contacts in gene expression control. Nat Rev Genet. 2019;20:437–55. https://doi.org/10.1038/s41576-019-0128-0.

Article  CAS  PubMed  Google Scholar 

Morton AR, Dogan-Artun N, Faber ZJ, MacLeod G, Bartels CF, Piazza MS, et al. Functional enhancers shape extrachromosomal oncogene amplifications. Cell. 2019;179:1330–1341 e1313. https://doi.org/10.1016/j.cell.2019.10.039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alekseyenko AA, Walsh EM, Wang X, Grayson AR, Hsi PT, Kharchenko PV, et al. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev. 2015;29:1507–23. https://doi.org/10.1101/gad.267583.115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roussos ET, Condeelis JS, Patsialou A. Chemotaxis in cancer. Nat Rev Cancer. 2011;11:573–87. https://doi.org/10.1038/nrc3078.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahin H, Trautwein C, Wasmuth HE. Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol. 2010;7:682–90. https://doi.org/10.1038/nrgastro.2010.168.

Article  CAS  PubMed  Google Scholar 

Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology. 2011;54:2185–97. https://doi.org/10.1002/hep.24599.

Article  CAS  PubMed  Google Scholar 

Zhang J, Patel L, Pienta KJ. Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic. Prog Mol Biol Transl Sci. 2010;95:31–53. https://doi.org/10.1016/B978-0-12-385071-3.00003-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222–5. https://doi.org/10.1038/nature10138.

Article  CAS  PubMed  PubMed Central  Google Scholar